Two Phase II Trials of Adavosertib, a Wee1 Inhibitor with Docetaxel or Carboplatin plus Pemetrexed in Non-small-cell Lung Cancer

20250 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov, NCT02087241 and NCT02087176.

Published in: Targeted Oncology

Volume 20, Issue 6, pp. 967-978

Field-Weighted Citation Impact: 0.00